معرفی
Jean Christophe Leroux is a Full Professor of Drug Formulation and Delivery at ETH Zurich's Department of Chemistry and Applied Biosciences, where he leads innovative research in pharmaceutical sciences from his laboratory at the Institute of Pharmaceutical Science.
His educational background includes:
- Pharmacy degree from the University of Montreal
- Doctorate in Pharmaceutical Sciences from the University of Geneva (1995)
- Postdoctoral studies at the University of California, San Francisco (1996-1997)
Professor Leroux's research focuses on groundbreaking approaches to drug delivery systems. His work spans the design and synthesis of novel biopolymers, development of environmentally-responsive drug delivery systems including liposomes, micelles, and gels, and targeted tumor therapies. More recently, his laboratory has pioneered research on polymer-based treatments for celiac disease, representing a novel approach to managing this autoimmune disorder. His interdisciplinary work bridges pharmaceutical science, polymer chemistry, and biomedical engineering to create smarter drug delivery solutions that respond to physiological cues.
Throughout his distinguished career, Professor Leroux has received significant recognition including:
- Canada Research Chair in Drug Delivery (2001)
Professor Leroux actively mentors graduate students and has secured substantial research funding to advance his innovative work in drug delivery technologies. He teaches several key courses at ETH Zurich including Drug Delivery and Drug Targeting, Galenic Pharmacy, and Seminars on Drug Discovery and Development, shaping the next generation of pharmaceutical scientists.
He leads a vibrant research group at the Institute of Pharmaceutical Science, which maintains state-of-the-art facilities for polymer synthesis, drug formulation, and in vitro testing of novel delivery systems. The laboratory maintains strong collaborations with both academic institutions and pharmaceutical industry partners to translate basic research into clinical applications, with particular emphasis on developing smarter, more effective drug delivery platforms.
